-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RJEmoIWSij+a9Cg/J7uMPX8e8o5ZyKyXdCP+fdOtJ18vCH3LC5OAto1KXandMGV5 LIBsQCd01aFCLigd/SNSyw== 0000891618-97-000698.txt : 19970222 0000891618-97-000698.hdr.sgml : 19970222 ACCESSION NUMBER: 0000891618-97-000698 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970214 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CALYPTE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000899426 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061226727 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-50235 FILM NUMBER: 97536253 BUSINESS ADDRESS: STREET 1: 1440 FOURTH STREET CITY: BERKELEY STATE: CA ZIP: 94710 MAIL ADDRESS: STREET 1: 1265 HARBOR BAY PKWY CITY: ALAMEDA STATE: CA ZIP: 94502 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SUEZ TECHNOLOGY FUND CENTRAL INDEX KEY: 0001033379 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 980080610 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 2180 SAND HILL RD STE 450 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 4158540587 SC 13G 1 SCHEDULE 13G 1 -------------------------------- OMB APPROVAL -------------------------------- OMB Number: 3235-0145 Expires: December 31, 1997 Estimated average burden hours per response.........14.90 -------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ____________)* CALYPTE BIOMEDICAL CORPORATION ________________________________________________________________________________ (Name of Issuer) COMMON STOCK ________________________________________________________________________________ (Title of Class of Securities) 0000899426 ________________________________________________________________________________ (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SEC 1745 (2-95) Page 1 of 5 Pages 2 SCHEDULE 13G - --------------------- ----------------- CUSIP NO. 0000899426 Page 2 of 5 Pages - --------------------- ----------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON SUEZ TECHNOLOGY FUND/GUY H. CONGER/ NANCY D. BURRIS/ DAVID E. GOLD S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON ###-##-####/292/292488634/523761929/339327461 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Menlo Park, California - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF ------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 557,453 common shares 5.3% OWNED BY ------------------------------------------------------------- EACH REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH ------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 557,453 common shares 5.3% - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 557,453 common shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.3% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT 3 CUSIP No. 0000899426 Page 3 of 5 Pages ---------- ITEM 1. (a) Name of Issuer CALYPTE BIOMEDICAL CORPORATION (b) Address of Issuer's Principal Executive Offices 1440 Fourth Street Berkeley, Ca. 94710 ITEM 2. (a) Name of Person Filing SUEZ TECHNOLOGY FUND (b) Address of Principal Business Office or, if none, Residence 2180 Sand Hill Road, Suite 450, Menlo Park, CA 94028 (c) Citizenship USA (d) Title of Class of Securities COMMON STOCK (e) CUSIP Number ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON IS A: (a) / / Broker or Dealer registered under Section 15 of the Act (b) / / Bank as defined in section 3(a)(6) of the Act (c) / / Insurance Company as defined in section 3(a)(19) of the Act (d) / / Investment Company registered under section 8 of the Investment Company Act (e) / / Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 (f) / / Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund, see section 240.13d-1(b)(1)(ii)(F) (g) / / Parent Holding Company, in accordance with section 240.13d- 1(b)(1)(ii)(G) (Note:See Item 7) (h) / / Group, in accordance with section 240.13d-1(b)(1)(ii)(H) ITEM 4. OWNERSHIP (a) Amount Beneficially Owned 557,453 common shares (b) Percent of Class 5.3% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote (ii) shared power to vote or direct the vote, Guy H. Conger, Nancy D. Burris, David E. Gold: 557,453 common shares (iii) sole power to dispose or direct the disposition of (iv) shared power to dispose or direct the disposition of , Guy H. Conger, Nancy D. Burris, David E. Gold: 557,453 common shares 4 CUSIP No. 0000899426 Page 4 of 5 Pages ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following / /. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP ITEM 9. NOTICE OF DISSOLUTION OF GROUP 5 CUSIP No. 0000899426 Page 5 of 5 Pages ITEM 10. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. We agree to file this 13g together. February 14, 1997 ------------------------------- Date ------------------------------- Signature Suez Technology Fund ------------------------------- Name/Title February 14, 1997 ------------------------------- Date /s/ GUY H. CONGER ------------------------------- Signature Guy H. Conger ------------------------------- Name/Title February 14, 1997 ------------------------------- Date /s/ NANCY D. BURRIS ------------------------------- Signature Nancy D. Burris ------------------------------- Name/Title ------------------------------- Date ------------------------------- Signature David E. Gold ------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----